Mukka Proteins Ltd Stock Hits 52-Week Low Amidst Continued Downtrend

Stock Performance and Market Context

The stock has declined steadily over the past five trading sessions, registering a cumulative loss of 2.37% during this period. Despite this, it marginally outperformed the broader FMCG sector today by 1.59%, even as the aquaculture segment, to which Mukka Proteins belongs, fell by 2.18%. The broader market, represented by the Sensex, opened lower by 183.12 points and is currently trading at 84,777.96, down 0.22%. Notably, the Sensex remains 1.63% below its 52-week high of 86,159.02, with the index trading below its 50-day moving average, though the 50DMA remains above the 200DMA, signalling mixed technical signals.

Mukka Proteins is trading below all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — underscoring the prevailing bearish momentum. The stock’s 52-week high was Rs.41.08, indicating a steep decline of approximately 43.5% from that peak.

Financial Metrics and Profitability Concerns

The company’s financial indicators reveal several areas of concern. Mukka Proteins has reported a Return on Capital Employed (ROCE) of 9.16%, which is considered low and indicative of limited profitability relative to the capital invested. This figure has contributed to the stock’s current Mojo Grade of Sell, a downgrade from its previous Strong Sell rating as of 14 Nov 2025. The Mojo Score stands at 31.0, reflecting subdued fundamentals.

Debt servicing capacity remains a challenge, with a high Debt to EBITDA ratio of 5.26 times. This elevated leverage ratio suggests that the company’s earnings before interest, taxes, depreciation, and amortisation are insufficiently robust to comfortably cover its debt obligations. Interest expenses have reached a quarterly high of Rs.12.82 crores, further pressuring profitability.

Net sales growth has been modest, averaging 8.60% annually over the past five years, which is below expectations for sustained expansion in the FMCG sector. The company has also reported negative results for seven consecutive quarters, with Profit Before Tax (excluding other income) falling by 67.9% to Rs.3.28 crores in the most recent quarter compared to the previous four-quarter average. Similarly, Profit After Tax declined by 45.9% to Rs.5.88 crores over the same period.

Institutional Participation and Market Sentiment

Institutional investors have reduced their holdings by 0.6% in the previous quarter, now collectively holding 3.36% of the company’s shares. This decline in institutional stake may reflect cautious sentiment given the company’s recent financial performance and valuation metrics. Institutional investors typically possess greater analytical resources, and their reduced participation can signal concerns about the company’s near-term prospects.

Long-Term and Relative Performance

Over the past year, Mukka Proteins has delivered a negative return of 38.90%, significantly underperforming the Sensex, which posted an 8.42% gain over the same period. The stock has also lagged behind the BSE500 index across one-year, three-year, and three-month timeframes, indicating persistent underperformance relative to broader market benchmarks.

Despite these challenges, the company has demonstrated healthy long-term growth in operating profit, which has increased at an annual rate of 50.86%. This growth, however, has not translated into improved bottom-line results or market valuation.

Valuation and Market Capitalisation

Mukka Proteins currently holds a Market Cap Grade of 4, reflecting its micro-cap status within the FMCG sector. The stock trades at a discount relative to its peers’ historical valuations, with an Enterprise Value to Capital Employed ratio of 1.3, which is considered very attractive. This valuation metric suggests that the market is pricing in the company’s current challenges and subdued profitability.

Summary of Key Financial Indicators

The company’s recent quarterly results highlight a contraction in profitability, with PBT (excluding other income) at Rs.3.28 crores, down 67.9%, and PAT at Rs.5.88 crores, down 45.9% compared to the previous four-quarter average. Interest expenses have escalated to Rs.12.82 crores, the highest recorded in recent quarters, reflecting increased financial costs.

Return on Capital Employed remains subdued at 9.16%, while the Debt to EBITDA ratio of 5.26 times indicates elevated leverage. Net sales growth of 8.60% annually over five years is modest within the FMCG sector context. The stock’s 52-week low of Rs.23.2 represents a significant decline from its 52-week high of Rs.41.08, underscoring the challenges faced by the company.

Sectoral and Market Dynamics

The aquaculture sector, which forms part of the broader FMCG industry, has experienced a decline of 2.18%, reflecting sector-wide pressures. Mukka Proteins’ relative outperformance today by 1.59% against this backdrop is a minor positive note amid the prevailing downtrend. The Sensex’s current position below its 50-day moving average, despite the 50DMA trading above the 200DMA, indicates a cautious market environment.

Conclusion

Mukka Proteins Ltd’s stock reaching a new 52-week low at Rs.23.2 reflects a combination of subdued profitability, elevated debt levels, and cautious institutional participation. While the company has shown strong operating profit growth over the long term, this has not translated into improved net earnings or market performance. The stock’s valuation remains discounted relative to peers, consistent with its current financial profile and market sentiment.

Investors and market participants will continue to monitor the company’s financial metrics and sectoral developments as Mukka Proteins navigates these challenges.

Unlock special upgrade rates for a limited period. Start Saving Now →